Sanofi India Limited
Aditya Birla Sun Life Mutual Fund reduced its stake in Sanofi India from 2.32% to 2.04%, selling 65,492 shares.
A leading multinational pharmaceutical company operating in India, Sanofi India manufactures and distributes medicines across multiple therapeutic areas including diabetes, cardiology, thrombosis, central nervous system disorders, and anti-histamines. The company serves patients and healthcare providers through a comprehensive portfolio of pharmaceutical products designed to address diverse medical conditions. Its established presence in India's pharmaceutical market reflects its commitment to improving health outcomes across the country.
Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Among India's top five AMCs with over Rs 6.5 lakh crore in AUM across 100+ schemes. MD and CEO A. Balasubramanian is one of the most outspoken fund industry voices in India. CIO Mahesh Patil oversees the equity book with a consistent large and multicap tilt.